0,945  0,002  NOS2 expression inhibitor
0,899  0,001  Melanin inhibitor
0,871  0,009  Apoptosis agonist
0,836  0,003  Skin whitener
0,838  0,011  Transcription factor NF kappa B inhibitor
0,827  0,003  Monophenol monooxygenase inhibitor
0,806  0,004  Caspase 3 stimulant
0,806  0,005  Chemopreventive
0,801  0,004  Antioxidant
0,786  0,010  Antineoplastic (breast cancer)
0,781  0,007  Antileukemic
0,772  0,004  AR expression inhibitor
0,774  0,019  Antiinflammatory
0,736  0,005  Cardiovascular analeptic
0,723  0,005  Antiosteoporotic
0,712  0,005  Antineoplastic (glioma)
0,710  0,006  UGT1A9 substrate
0,716  0,016  Antineoplastic (lung cancer)
0,699  0,005  Antiprotozoal (Leishmania)
0,716  0,022  Caspase 9 stimulant
0,693  0,003  NOS3 expression enhancer
0,689  0,008  Bone diseases treatment
0,683  0,005  Free radical scavenger
0,682  0,009  CYP2C19 substrate
0,687  0,015  Antineoplastic (colorectal cancer)
0,677  0,006  Nitric oxide antagonist
0,680  0,011  Respiratory analeptic
0,683  0,015  Antineoplastic (colon cancer)
0,672  0,006  Lipoxygenase inhibitor
0,672  0,008  Proliferative diseases treatment
0,669  0,015  15-Lipoxygenase inhibitor
0,645  0,014  Antihypercholesterolemic
0,637  0,006  Antiamyloidogenic
0,621  0,005  Antineoplastic (glioblastoma multiforme)
0,599  0,008  Hypoxia-inducible factor 1 alpha inhibitor
0,586  0,020  Prostate cancer treatment
0,574  0,013  Cardioprotectant
0,577  0,029  TNF expression inhibitor
0,550  0,004  Protein-tyrosine phosphatase 1B inhibitor
0,560  0,017  Radioprotector
0,551  0,008  Vascular (periferal) disease treatment
0,547  0,004  Antihypotensive
0,556  0,020  Antineoplastic (ovarian cancer)
0,561  0,026  Antibacterial
0,543  0,011  CYP1A2 inhibitor
0,549  0,019  Sensitization
0,545  0,014  Antineoplastic (brain cancer)
0,529  0,005  Protein-tyrosine phosphatase inhibitor
0,532  0,009  Antihypertriglyceridemic
0,515  0,005  VCAM1 expression inhibitor
0,527  0,018  CYP2C19 inhibitor
0,525  0,017  Apoptosis antagonist
0,564  0,062  Alpha-glucosidase inhibitor
0,504  0,007  UGT1A3 substrate
0,508  0,011  Vasodilator
0,531  0,039  Alzheimer's disease treatment
0,504  0,022  Analeptic
0,494  0,016  Hypoglycemic
0,492  0,023  Chemoprotective
0,478  0,015  Antineoplastic (lymphoma)
0,476  0,026  Hepatic disorders treatment
0,453  0,004  Estrogen agonist
0,488  0,040  Antiprotozoal
0,450  0,007  Lipid peroxidase inhibitor
0,466  0,024  Cytostatic
0,444  0,004  Estrogen antagonist
0,463  0,025  NOS3 expression inhibitor
0,491  0,053  Cyclophilin D inhibitor
0,491  0,053  Antidiabetic
0,455  0,022  ICAM1 expression inhibitor
0,452  0,020  Antipyretic
0,434  0,004  Estrogen receptor beta antagonist
0,458  0,029  Antineoplastic (melanoma)
0,459  0,032  CYP2D6 substrate
0,438  0,016  UDP-glucuronosyltransferase substrate
0,435  0,019  UGT1A6 substrate
0,429  0,014  UGT1A1 substrate
0,459  0,044  Immunosuppressant
0,429  0,014  Antimutagenic
0,416  0,004  Estrogen receptor alpha antagonist
0,423  0,011  Hepatoprotectant
0,440  0,030  Lipoprotein disorders treatment
0,417  0,010  Genotoxic
0,436  0,032  Cytotoxic
0,442  0,054  Histamine release inhibitor
0,411  0,023  Antiparasitic
0,406  0,024  Amyloid beta aggregation inhibitor
0,395  0,017  Antihelmintic
0,411  0,034  Antineoplastic (cervical cancer)
0,388  0,013  Platelet adhesion inhibitor
0,370  0,004  Electron transport complex I inhibitor
0,387  0,025  Myocardial infarction treatment
0,373  0,014  Antineoplastic (squamous cell carcinoma)
0,395  0,039  Antineoplastic (pancreatic cancer)
0,389  0,034  Antineoplastic (multiple myeloma)
0,399  0,046  Antifungal
0,363  0,012  Amylase inhibitor
0,380  0,032  Antiprotozoal (Trypanosoma)
0,349  0,013  Topoisomerase II inhibitor
0,361  0,026  Antineoplastic (lymphocytic leukemia)
0,364  0,032  Antidiabetic symptomatic
0,334  0,004  Estrogen receptor beta agonist
0,345  0,016  MAO inhibitor
0,361  0,033  Antineoplastic (renal cancer)
0,360  0,035  Tumour necrosis factor alpha release inhibitor
0,376  0,069  CYP3A4 substrate
0,349  0,044  UGT2B4 substrate
0,353  0,056  12-Lipoxygenase inhibitor
0,302  0,008  Neurotrophic factor
0,298  0,009  Antihemorrhagic
0,299  0,010  Heat shock protein 90 antagonist
0,294  0,006  Beta glucuronidase inhibitor
0,291  0,004  Papain-like protease (SARS coronavirus) inhibitor
0,287  0,006  Beta amyloid protein antagonist
0,287  0,010  LDLR expression enhancer
0,279  0,003  Neuraminidase inhibitor
0,284  0,008  Topoisomerase II alpha inhibitor
0,314  0,039  Antiulcerative
0,297  0,027  UGT2B7 substrate
0,275  0,005  Postmenopausal disorders treatment
0,283  0,020  UGT2B15 substrate
0,302  0,051  Antineoplastic (liver cancer)
0,313  0,064  Antineoplastic (small cell lung cancer)
0,275  0,026  Neurotrophic factor enhancer
0,258  0,014  Cystathionine beta-synthase inhibitor
0,245  0,004  Neuraminidase (influenza) inhibitor
0,246  0,006  Gastritis treatment
0,312  0,072  Antimycobacterial
0,255  0,016  MAO B inhibitor
0,256  0,019  Antidiarrheal
0,330  0,094  CYP2C9 inhibitor
0,264  0,029  Antiviral (Herpes)
0,252  0,021  Cyclooxygenase 1 inhibitor
0,264  0,037  P-glycoprotein inhibitor
0,275  0,051  Antimitotic
0,297  0,073  CTGF expression inhibitor
0,239  0,017  5-Lipoxygenase inhibitor
0,293  0,075  Antineoplastic (osteosarcoma)
0,247  0,031  Antineoplastic (carcinoma)
0,220  0,005  Lipase inhibitor
0,238  0,024  UGT2B9 substrate
0,252  0,040  UGT1A4 substrate
0,286  0,075  Spasmolytic
0,309  0,101  CYP2C9 substrate
0,275  0,067  Antineoplastic (non-small cell lung cancer)
0,207  0,004  Ca(v)3.1 blocker
0,295  0,099  Vasodilator, peripheral
0,258  0,064  Hypolipemic
0,202  0,008  Aromatase inhibitor
0,261  0,068  Superoxide dismutase inhibitor
0,340  0,147  Antineoplastic (solid tumors)
0,211  0,030  Acetylcholinesterase inhibitor
0,184  0,005  Ornithine decarboxylase inhibitor
0,204  0,026  Cholesterol synthesis inhibitor
0,261  0,084  GST M1-1 substrate
0,279  0,106  Vasodilator, coronary
0,218  0,045  Diabetic nephropathy treatment
0,191  0,024  Farnesoid X receptor antagonist
0,169  0,005  Estrogen receptor alpha agonist
0,220  0,061  Mutagenic
0,166  0,019  Breast cancer-resistant protein inhibitor
0,218  0,072  Antineoplastic enhancer
0,242  0,097  Antidiabetic (type 2)
0,184  0,043  Tubulin antagonist
0,177  0,038  Psychosexual dysfunction treatment
0,169  0,034  Antibacterial (Helicobacter pylori)
0,177  0,042  SULT1A3 substrate
0,181  0,050  Cyclooxygenase inhibitor
0,180  0,050  Protein kinase stimulant
0,218  0,089  Platelet antagonist
0,237  0,110  Antihypoxic
0,238  0,111  Streptokinase A inhibitor
0,163  0,037  Topoisomerase I inhibitor
0,236  0,111  CYP1A2 substrate
0,197  0,073  Abortion inducer
0,183  0,064  Succinate dehydrogenase inhibitor
0,196  0,077  Antiviral (Influenza)
0,176  0,059  Arachidonic acid antagonist
0,129  0,014  Leukotriene synthesis inhibitor
0,129  0,014  Leukotriene antagonist
0,137  0,022  ABCA1 expression enhancer
0,143  0,028  Dementia treatment
0,158  0,045  DNA polymerase I inhibitor
0,145  0,035  Alpha 2c adrenoreceptor antagonist
0,169  0,060  Phospholipase A2 inhibitor
0,137  0,028  Vascular dementia treatment
0,145  0,036  Xanthine oxidase inhibitor
0,126  0,020  Keratolytic
0,166  0,060  Interferon gamma antagonist
0,111  0,005  Transcription factor RelA inhibitor
0,189  0,085  Insulin sensitizer
0,212  0,109  Antineoplastic (sarcoma)
0,174  0,071  Antineoplastic (bone cancer)
0,197  0,094  Nitric-oxide synthase stimulant
0,181  0,079  Carcinogenic
0,166  0,065  Cholinergic
0,244  0,147  Ulceration
0,131  0,036  Antineoplastic antibiotic
0,140  0,046  Antineoplastic (uterine cancer)
0,116  0,024  Bile acid receptor antagonist
0,136  0,046  MAO A inhibitor
0,136  0,046  Glutathione S-transferase substrate
0,233  0,147  Sodium/bile acid cotransporter inhibitor
0,130  0,046  Mucolytic
0,115  0,031  Phosphodiesterase 4D inhibitor
0,213  0,129  5 Hydroxytryptamine uptake stimulant
0,144  0,063  Antifungal enhancer
0,160  0,082  UGT2B10 substrate
0,196  0,119  DNA damaging
0,090  0,014  Fatty acid synthase inhibitor
0,099  0,025  SULT1A2 substrate
0,108  0,034  Carbonic anhydrase XIII inhibitor
0,077  0,004  Sodium/glucose cotransporter 2 inhibitor
0,109  0,039  SULT1E1 substrate
0,100  0,032  Na+ K+ transporting ATPase inhibitor
0,116  0,051  UGT2B1 substrate
0,135  0,072  Bone formation stimulant
0,170  0,109  Pneumotoxic
0,121  0,059  Microtubule formation inhibitor
0,119  0,059  TRPA1 agonist
0,092  0,033  Peroxisome proliferator-activated receptor gamma agonist
0,213  0,155  Angiogenesis inhibitor
0,070  0,014  Leukotriene C antagonist
0,137  0,081  Antifungal (Cryptococcus)
0,091  0,034  Histone deacetylase SIRT1 stimulant
0,091  0,034  Histone deacetylase stimulant
0,112  0,056  Antiviral (Coronavirus)
0,112  0,056  Antiviral (SARS coronavirus)
0,130  0,075  Alkaline phosphatase inhibitor
0,110  0,059  Expectorant
0,055  0,005  Sodium/glucose cotransporter inhibitor
0,181  0,131  RNA-directed DNA polymerase inhibitor
0,075  0,025  Aldose reductase inhibitor
0,196  0,146  Antiischemic
0,162  0,112  CYP2B6 inhibitor
0,069  0,020  Leukotriene B4 antagonist
0,103  0,054  UGT2B11 substrate
0,124  0,076  Renal failure treatment
0,105  0,057  Sulfotransferase substrate
0,099  0,051  Alpha 2d adrenoreceptor antagonist
0,097  0,050  Actinic keratosis treatment
0,065  0,019  Glucose-6-phosphate translocase inhibitor
0,141  0,095  Prostatic (benign) hyperplasia treatment
0,152  0,108  Toxic, respiratory center
0,105  0,062  Toll-Like receptor 4 antagonist
0,119  0,076  Coagulant
0,085  0,045  Alpha 2a adrenoreceptor antagonist
0,147  0,109  Antineoplastic (gastric cancer)
0,235  0,198  Antiparkinsonian
0,174  0,137  Immunostimulant
0,103  0,066  HDL-cholesterol increasing
0,090  0,055  Alpha 2 adrenoreceptor antagonist
0,213  0,180  Antiprotozoal (Plasmodium)
0,142  0,108  Diabetic retinopathy treatment
0,066  0,034  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,115  0,083  Cyclooxygenase 3 inhibitor
0,084  0,053  Thioredoxin reductase inhibitor
0,107  0,076  Photosensitizer
0,040  0,011  Leukotriene B4 receptor 1 antagonist
0,090  0,061  Thioredoxin inhibitor
0,047  0,019  Retinoid X receptor agonist
0,217  0,190  Antiobesity
0,039  0,012  Estrogen-related receptor beta antagonist
0,032  0,008  Leukotriene B4 receptor 2 antagonist
0,041  0,019  Retinoid X alpha receptor agonist
0,075  0,054  Antitreponemal
0,058  0,037  Postcoital contraceptive
0,075  0,056  NAD(P)H dehydrogenase (quinone) inhibitor
0,134  0,115  Dual specificity phosphatase inhibitor
0,089  0,072  Butyrylcholinesterase inhibitor
0,043  0,026  Cathepsin L2 inhibitor
0,048  0,032  Potassium channel Kv1.3 blocker
0,053  0,037  Alpha tubulin antagonist
0,065  0,051  Potassium channel large-conductance Ca-activated activator
0,131  0,117  Ca2+-transporting ATPase inhibitor
0,027  0,014  Sodium/glucose cotransporter 1 inhibitor
0,107  0,094  Alcohol dehydrogenase substrate
0,092  0,079  Mediator release inhibitor
0,091  0,078  Urease inhibitor
0,097  0,085  Antihypermotility
0,078  0,068  Antineoplastic alkaloid
0,056  0,047  Androgen agonist
0,068  0,060  CDC25A inhibitor
0,095  0,087  SULT1A1 substrate
0,127  0,118  Antipruritic, non-allergic
0,113  0,105  Vanilloid 1 agonist
0,136  0,131  Teratogen
0,051  0,046  Beta tubulin antagonist
0,041  0,036  Alpha 1L adrenoreceptor agonist
0,077  0,073  Opioid antagonist
0,136  0,132  Angiogenesis stimulant
0,019  0,015  Inosine monophosphate dehydrogenase 1 inhibitor
0,055  0,053  HIV-1 integrase (3'-Processing) inhibitor
0,036  0,034  Retinoic acid alpha receptor agonist

